MOG and myeloid sarcoma: In neuro-ophthalmic disorders, this integration could detect disruptions in the visual pathway, including optic nerve damage (as seen in MS, NMO, and MOG antibody disease) or cortical involvement in the visual cortex, which may precede overt clinical symptoms.